WHC is still in active development. Read this to understand our approach.
depiction of VOKSWYLNZZRQPF-UHFFFAOYSA-N.svg
tripsit

pentazocine

Verificar en tripsit

isomerdesign

Pentazocine

Verificar en isomerdesign

pubchem

Pentazocine

Verificar en pubchem

drugmap

Pentazocine

Verificar en drugmap

drugmap

Pentazocine

Verificar en drugmap

wiki

Pentazocine

Verificar en wiki

Data

InChI: InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3

Sinónimos: NIH 7958, Fortal (TN),Pentagin,Pentazocine [USAN:USP:INN:BAN:JAN],RP4A60D26L,2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan,Pentazocinum, Fortral,Pentazocine civ, (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol,CHEMBL560,WIN-20228,Fortral (TN),(2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol,(+)-[3H]-Pentazocine, Pentazocine (JP15/USP/INN),Sosigon,Pentazocine,359-83-1,UNII-RP4A60D26L,PENTAZOCINE [EP MONOGRAPH], Talwin NX (TN),KF-1820,(+)-Pentazocine,D00498,Pentazocine 2R,6R,11R-form,WIN 20,228, Pentagin, 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan,(+-)-Pentazocine,cis-(+-)-Pentazocine,Pentazocine, L-,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-,PENTAZOCINE [MART.], KF-1820, Pentazocaine,Pentazocine,(+/-),Pentazocine, (-)-,cis-(-)-Pentazocine,359-83-1 (free base),Fortalgesic,UNII-768DQ5A5AI,DB00652,SCHEMBL2492,Pentazocine 2R,6R,11R-form [MI],2-(3,3-Dimethylallyl)cyclazocine,2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, (2R,6R,11R)-,dl-Pentazocine, (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)-,PENTAZOCINE [USAN],768DQ5A5AI,II-C-2, Fortalin,Q415793,3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol,EINECS 206-634-6, Talwin PX (TN),(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol,7488-49-5, Fortral (TN), Pentazocine [USAN:INN:BAN:JAN], Pentazocinum [INN-Latin], L-pentazocine,DTXSID7023433,Fortalin, Talwin (TN), 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol,PENTAZOCINE [INN], Pentazocinum,(-)-alpha-Pentazocine,2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, CIS-(-)-,PENTAZOCINE [MI],talwin, WIN 20228,PENTAZOCINE [HSDB],PENTAZOCINE (+),GTPL1606,(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2,4,6-trien-4-ol,(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2,4,6-trien-4-ol,(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2(7),3,5-trien-4-ol,ZINC596,PENTAZOCINE [EP IMPURITY],(+/-)-pentazocine,HSDB 3150, Pentazocina, Talacen,6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Pentazocine),rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol, 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan, Soseton,Pentazocaine,Pentazocina [DCIT],(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-rel-,Levopentazocine,PENTAZOCINE (-), (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol,Pentazocin,Pentazocinum [INN-Latin],Pentazocina, Talwan,(2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol,PENTAZOCINE [JAN],(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol,NSC 107430, CHEMBL2311194,cis-(+/-)-Pentazocine, 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol,(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol, Pentazocine, Pentazocin, Sosegon, WIN 20228,Sosegon,(-)-PENTAZOCINE,WIN 20228,(2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol, 2-(3,3-Dimethylallyl)cyclazocine, Algopent (free base),Pentazocine (JP17/USP/INN),C07421, Sosigon, 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol,(6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-,(-)-.ALPHA.-PENTAZOCINE,L-pentazocine,CHEBI:7982,FT-0673607,2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan,2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan, Pentazocin,pentazocine, Talacen (TN), II-C-2, 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan,NIH-7958, NIH 7958,PENTAZOCINE [WHO-DD],PENTAZOCINE [USP MONOGRAPH],[3H]pentazocine,EINECS 244-593-6, Liticon, [3H]pentazocine, Sosegon,PENTAZOCINE CIV [USP-RS], Lexir, Fortwin (TN), Pentazocina [DCIT],6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol,BDBM50001028, [3H]-(+)-Pentazocine,PENTAZOCINE [VANDF]

Estimated data

Solubilidad: -3.656 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 98.0% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.